by Trish Adkins
When Eirini Papapetrou, MD, PhD from the Icahn School of Medicine at Mount Sinai started her lab, she devoted her research to developing specialized iPSC models.
This might not mean a lot to those of us who are not researchers. But these models—made from patient-derived cells—could be the key to understanding the drivers behind certain types of acute myeloid leukemia (AML), one of the most difficult and deadliest types of pediatric leukemia.
The development of iPSC... Read More